A neuronal mechanism underlying decision-making deficits during hyperdopaminergic states

被引:0
作者
Jeroen P. H. Verharen
Johannes W. de Jong
Theresia J. M. Roelofs
Christiaan F. M. Huffels
Ruud van Zessen
Mieneke C. M. Luijendijk
Ralph Hamelink
Ingo Willuhn
Hanneke E. M. den Ouden
Geoffrey van der Plasse
Roger A. H. Adan
Louk J. M. J. Vanderschuren
机构
[1] University Medical Center Utrecht,Department of Translational Neuroscience, Brain Center Rudolf Magnus
[2] Utrecht University,Department of Animals in Science and Society, Division of Behavioural Neuroscience, Faculty of Veterinary Medicine
[3] University of California,Department of Molecular and Cell Biology and Helen Wills Neuroscience Institute
[4] Berkeley,Netherlands Institute for Neuroscience
[5] Institute of the Royal Netherlands Academy of Arts and Sciences,Department of Psychiatry, Academic Medical Center
[6] University of Amsterdam,Donders Institute for Brain, Cognition and Behavior
[7] Radboud University,undefined
来源
Nature Communications | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Hyperdopaminergic states in mental disorders are associated with disruptive deficits in decision making. However, the precise contribution of topographically distinct mesencephalic dopamine pathways to decision-making processes remains elusive. Here we show, using a multidisciplinary approach, how hyperactivity of ascending projections from the ventral tegmental area (VTA) contributes to impaired flexible decision making in rats. Activation of the VTA–nucleus accumbens pathway leads to insensitivity to loss and punishment due to impaired processing of negative reward prediction errors. In contrast, activation of the VTA–prefrontal cortex pathway promotes risky decision making without affecting the ability to choose the economically most beneficial option. Together, these findings show how malfunction of ascending VTA projections affects value-based decision making, suggesting a potential mechanism through which increased forebrain dopamine signaling leads to aberrant behavior, as is seen in substance abuse, mania, and after dopamine replacement therapy in Parkinson’s disease.
引用
收藏
相关论文
共 133 条
  • [1] Murphy FC(2001)Decision-making cognition in mania and depression Psychol. Med. 31 679-693
  • [2] Johnson SL(2005)Mania and dysregulation in goal pursuit: a review Clin. Psychol. Rev. 25 241-262
  • [3] Rogers RD(1999)Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms Neuropsychopharmacology 20 322-339
  • [4] Grant S(2000)Drug abusers show impaired performance in a laboratory test of decision making Neuropsychologia 38 1180-1187
  • [5] Contoreggi C(2013)A neurocognitive approach to understanding the neurobiology of addiction Curr. Opin. Neurobiol. 23 632-638
  • [6] London ED(2014)New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity CNS Spectr. 19 69-89
  • [7] Noel X(2004)By carrot or by stick: cognitive reinforcement learning in parkinsonism Science 306 1940-1943
  • [8] Brevers D(2006)Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease Neurosci. Biobehav. Rev. 30 1-23
  • [9] Bechara A(2015)The brain on drugs: from reward to addiction Cell 162 712-725
  • [10] Fineberg NA(2015)The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited Eur. J. Pharmacol. 753 114-126